Julia Sastre-Marcos

Toledo, CM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum: Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors.

Corrigendum: Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors.

Journal: Frontiers in endocrinology

Published: December 10, 2024

Papillary thyroid carcinoma on thyroglossal duct cyst: A series of 7 cases.

Papillary thyroid carcinoma on thyroglossal duct cyst: A series of 7 cases.

Journal: Endocrinologia, diabetes y nutricion

Published: September 07, 2024

Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors.

Bone metastasis in differentiated thyroid cancer: Spanish multicenter study of clinical characteristics, survival and prognostic factors.

Journal: Frontiers in endocrinology

Published: July 17, 2024

All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010-2020 study.

All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010-2020 study.

Journal: Primary care diabetes

Published: January 12, 2023

"Clinical status and mortality in older adults with type 1 diabetes: Results from a public health system".

"Clinical status and mortality in older adults with type 1 diabetes: Results from a public health system".

Journal: Diabetes research and clinical practice

Published: December 09, 2021

Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study.

Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study.

Journal: Endocrinologia, diabetes y nutricion

Published: May 03, 2021

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Journal: Theranostics

Published: April 03, 2019

Follow-up and results in patients with differentiated thyroid carcinoma in Castilla-La Mancha (2001-2015). The CADIT-CAM study.

Follow-up and results in patients with differentiated thyroid carcinoma in Castilla-La Mancha (2001-2015). The CADIT-CAM study.

Journal: Endocrinologia, diabetes y nutricion

Published: May 31, 2018

Diagnosis Of Three Cases Of Thyroid Cancer In One Year

Diagnosis Of Three Cases Of Thyroid Cancer In One Year

Journal: Anales de pediatria

Published: February 22, 2018

Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer.

Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer.

Journal: European thyroid journal

Published: January 29, 2018

Primary thyroid lymphomas. Experience in hospitals of Castilla-La Mancha.

Primary thyroid lymphomas. Experience in hospitals of Castilla-La Mancha.

Journal: Endocrinologia, diabetes y nutricion

Published: October 08, 2017

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.

Journal: The Journal of molecular diagnostics : JMD

Published: February 10, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026